-
1
Adverse events in the nervous system associated with blinatumomab: a real-world study
Published 2025-02-01Subjects: Get full text
Article -
2
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
Published 2025-02-01Subjects: Get full text
Article -
3
Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA...
Published 2025-02-01Subjects: “…FDA adverse event reporting system…”
Get full text
Article